“We recently had the opportunity to collaborate with Consult Lhasa on the AI/ limit derivation of a new NDSRI. Given the challenge of limited specific data available for the queried nitrosamine, we sought Consult Lhasa’s expertise to enhance the robustness of our Read-Across approach. Their work is referenced in the latest global regulatory updates on nitrosamines, and this high level of scientific rigor was clearly reflected in their deliverables.
We sincerely thank the team for their deep scientific knowledge, timely efforts, and outstanding support.
We highly recommend Consult Lhasa and look forward to another productive collaboration in the future.”
